Startseite First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study

  • Paula J. Correa EMAIL logo , Pia Venegas , Yasna Palmeiro , Daniela Albers , Gregory Rice , Jaime Roa , Jorge Cortez , Max Monckeberg , Manuel Schepeler , Eduardo Osorio und Sebastian E. Illanes
Veröffentlicht/Copyright: 6. September 2018

Abstract

Objectives

To evaluate the first trimester maternal biomarkers for early pregnancy prediction of gestational diabetes mellitus (GDM).

Methods

The study was a case-control study of healthy women with singleton pregnancies at the first trimester carried out at the Obstetrics and Gynecology Unit, Clinica Davila, Santiago, Chile. After obtaining informed consent, peripheral blood samples of pregnant women under 14 weeks of gestation were collected. At 24–28 weeks of pregnancy, women were classified as GDM (n=16) or controls (n=80) based on the results of a 75-g oral glucose tolerance test (OGTT). In all women, we measured concentrations of fasting blood glucose, insulin, glycated hemoglobin, uric acid, cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), triglycerides, aspartate aminotransferase (AST), alanine aminotransferase (ALT), γ-glutamyl transpeptidase (GGT), alkaline phosphatase (AP), sex hormone-binding globulin (SHBG), adiponectin, tissue plasminogen activator (t-PA), leptin and placental growth factor (PGF).

Results

The GDM group displayed an increased median concentration of cholesterol (P=0.04), triglycerides (P=0.003), insulin (P=0.003), t-PA (P=0.0088) and homeostatic model assessment (HOMA) (P=0.003) and an increased mean concentration of LDL (P=0.009) when compared to the control group. The receiver operating characteristic (ROC) curve for significant variables achieved an area under the curve (AUC) of 0.870, a sensitivity of 81.4% and a specificity of 80.0%. The OGTT was positive for GDM according to the IADPSG (International Diabetes in Pregnancy Study Group) criteria.

Conclusion

Women who subsequently developed GDM showed higher levels of blood-borne biomarkers during the first trimester, compared to women who did not develop GDM. These data warrant validation in a larger cohort.


Corresponding author: Paula J. Correa, MD, Department of Obstetrics and Gynaecology and Laboratory of Reproductive Biology, Faculty of Medicine, Universidad de Los Andes, San Carlos de Apoquindo 2200, Las Condes, Santiago de Chile, Chile

Acknowledgments

We thank the Clinica Davila and the Obstetrics and Gynecology Department and Laboratory staff for their cooperation and for obtaining, storing and processing blood samples. We specially thank Stephanie Acuña from the Universidad of Los Andes Biology of Reproduction Laboratory for processing all the samples. Finally, we would like to acknowledge the contribution of Conicyt through regular FONDECYT code 1140119.

  1. Author contributions: Sebastian Illanes developed the original idea for the study, participated in the implementation, recruited patients and acquired the grant for funding. Paula Correa designed, coordinated and implemented the project; supervised the follow-up and evaluated the result and also wrote the report and submitted the article. Pia Venegas coordinated recruitment, interviewed and educated patients, recorded patient data, supervised sample extraction and follow-up and cooperated in results analysis. Yasna Palmeiro, Daniela Albers, Max Monckeberg and Gregory Rice participated in statistical analysis. Gregory Rice also supervised the manuscript development. Jorge Cortez, Jaime Roa, Manuel Schepeler and Eduardo Osorio recruited and followed-up patients. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: We acknowledge the funding from Conicyt CONICYT, MINSAL, Funder Id: 10.13039/501100002848. Grant Code FONIS SA133i20154.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Buchanan T, Xiang A. Gestational diabetes mellitus. J Clin Invest 2005;115:485–91.10.1172/JCI200524531Suche in Google Scholar

2. Albrecht S, Kuklina E, Bansil P, Jamieson D, Whiteman M, Kourtis A, et al. Diabetes trends among delivery hospitalizations in the U.S., 1994–2004. Diabetes Care 2010;33:768–73.10.2337/dc09-1801Suche in Google Scholar PubMed PubMed Central

3. Godfrey K, Barker D. Fetal programming and adult health. Public Health Nutr 2001;4:611–24.10.1079/PHN2001145Suche in Google Scholar PubMed

4. Yessoufou A, Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of metabolic memory. Exp Diabetes Res 2011;2011:218598.10.1155/2011/218598Suche in Google Scholar PubMed PubMed Central

5. Standards of Medical Care in Diabetes 2016: Summary of Revisions. Diabetes Care 2015;39(Suppl 1):S4–5.10.2337/dc16-S003Suche in Google Scholar PubMed

6. Landon M, Spong C, Thom E, Carpenter M, Ramin S, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339–48.10.1056/NEJMoa0902430Suche in Google Scholar PubMed PubMed Central

7. Monteiro L, Norman J, Rice G, Illanes S. Fetal programming and gestational diabetes mellitus. Placenta 2016;48:S54–60.10.1016/j.placenta.2015.11.015Suche in Google Scholar PubMed

8. Simmons D, Jelsma JG, Galjaard S, Devlieger R, van Assche A, Jans G, et al. Results from a European multicentre randomized trial of physical activity and/or healthy eating to reduce the risk of gestational diabetes mellitus: the DALI Lifestyle Pilot. Diabetes Care 2015;38:1650–6.10.2337/dc15-0360Suche in Google Scholar PubMed

9. Ainuddin JA, Kazi S, Aftab S, Kamran A. Metformin for preventing gestational diabetes in women with polycystic ovarian syndrome. J Coll Physicians Surg Pak 2015;25:237–41.Suche in Google Scholar

10. Riskin-Mashiah S, Damti A, Younes G, Auslender R. First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 2010;152:163–7.10.1016/j.ejogrb.2010.05.036Suche in Google Scholar PubMed

11. Georgiou H, Illanes S, Rice G. Novel screening approaches for the early detection of gestational diabetes mellitus. In: Radenkovic M, editor. Gestational diabetes. Chapter 1. Rijeka, Croatia: In-Tech; 2011. p. 1–20.Suche in Google Scholar

12. Bito T, Foldesi I, Nyari T, Pal A. Prediction of gestational diabetes mellitus in a high-risk group by insulin measurement in early pregnancy. Diabet Med 2005;22:1434–9.10.1111/j.1464-5491.2005.01634.xSuche in Google Scholar PubMed

13. Beneventi F, Simonetta M, Lovati E, Albonico G, Tinelli C, Locatelli E, et al. First trimester pregnancy-associated plasma protein-A in pregnancies complicated by subsequent gestational diabetes. Prenat Diagn 2011;31:523–8.10.1002/pd.2733Suche in Google Scholar PubMed

14. Caglar G, Ozdemir E, Cengiz S, Demirta S. Sex-hormone-binding globulin early in pregnancy for the prediction of severe gestational diabetes mellitus and related complications. J Obstet Gynaecol Res 2012;38:1286–93.10.1111/j.1447-0756.2012.01870.xSuche in Google Scholar PubMed

15. Savvidou M, Nelson S, Makgoba M, Messow C, Sattar N, Nicolaides K. First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes 2010;59:3017–22.10.2337/db10-0688Suche in Google Scholar PubMed PubMed Central

16. Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides K. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2010;31:135–41.10.1002/pd.2636Suche in Google Scholar PubMed

17. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82.10.2337/dc09-1848Suche in Google Scholar PubMed PubMed Central

18. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.10.1007/BF00280883Suche in Google Scholar PubMed

19. Gabbay-Benziv R, Doyle LE, Blitzer M, Baschat AA. First trimester prediction of maternal glycemic status. J Perinat Med 2015;43:283–9.10.1515/jpm-2014-0149Suche in Google Scholar PubMed

20. van Leeuwen M, Opmeer B, Zweers E, van Ballegooie E, ter Brugge H, de Valk H, et al. Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. Br J Obstet Gynecol 2010;117:69–75.10.1111/j.1471-0528.2009.02425.xSuche in Google Scholar PubMed

21. Li G, Kong L, Zhang L, Fan L, Su Y, Rose J, et al. Early pregnancy maternal lipid profiles and the risk of gestational diabetes mellitus stratified for body mass index. Reprod Sci 2014;22:712–7.10.1177/1933719114557896Suche in Google Scholar PubMed PubMed Central

22. Fahami F, Torabi S, Abdoli S. Prediction of glucose intolerance at 24–28 weeks of gestation by glucose and insulin level measurements in the first trimester. Iran J Nurs Midwifery Res 2015;20:81–6.Suche in Google Scholar

23. Ozcimen EE, Uckuyu A, Ciftci FC, Yanik FF, Bakar C. Diagnosis of gestational diabetes mellitus by use of the homeostasis model assessment-insulin resistance index in the first trimester. Gynecol Endocrinol 2008;24:224–9.10.1080/09513590801948416Suche in Google Scholar PubMed

24. Kumru P, Arisoy R, Erdogdu E, Demirci O, Kavrut M, Ard C, et al. Prediction of gestational diabetes mellitus at first trimester in low-risk pregnancies. Taiwan J Obstet Gynecol 2016;55: 815–20.10.1016/j.tjog.2016.04.032Suche in Google Scholar PubMed

25. Alptekin H, Çizmecioğlu A, Işık H, Cengiz T, Yildiz M, Iyisoy M. Predicting gestational diabetes mellitus during the first trimester using anthropometric measurements and HOMA-IR. J Endocrinol Invest 2016;39:577–83.10.1007/s40618-015-0427-zSuche in Google Scholar PubMed

26. Eliasson MC, Jansson J-H, Lindahl B, Stegmayr B. High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study. Cardiovasc Diabetol 2003;2:19.10.1186/1475-2840-2-19Suche in Google Scholar PubMed PubMed Central

Received: 2018-02-03
Accepted: 2018-07-23
Published Online: 2018-09-06
Published in Print: 2019-02-25

©2019 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Ultrasound Doppler waveform assessment: the story continues
  4. Review
  5. Association between increased antenatal vaginal pH and preterm birth rate: a systematic review
  6. Mini Review
  7. Update on uterine tachysystole
  8. Research Articles – Obstetrics
  9. First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study
  10. Emergency peripartal hysterectomy – a single-center analysis of the last 13 years at a tertiary perinatal care unit
  11. Efficacy and safety of misoprostol vaginal insert vs. oral misoprostol for induction of labor
  12. Vitamin A and β-carotene in pregnant and breastfeeding post-bariatric women in an urban population
  13. Effect of dual tocolysis with fenoterol and atosiban in human myometrium
  14. Antecedents of red cell transfusion in a large contemporary obstetric cohort
  15. Effect of n-3 long-chain polyunsaturated fatty acids supplementation in healthy mothers on DHA and EPA profiles in maternal and umbilical blood: a randomized controlled trial
  16. Research Articles – Fetus
  17. Effect of psychotropic drugs on fetal behavior in the third trimester of pregnancy
  18. Prognostic value of the aortic isthmus Doppler assessment on late onset fetal growth restriction
  19. Doppler evaluation of the fetal pulmonary artery pressure
  20. Mechanisms of death in structurally normal stillbirths
  21. The diagnostic value of a detailed first trimester anomaly scan in fetuses with increased nuchal translucency thickness
  22. Research Articles – Newborn
  23. Small for gestational age and extremely low birth weight infant outcomes
  24. Does heart rate variability improve prediction of failed extubation in preterm infants?
Heruntergeladen am 28.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpm-2018-0120/html?lang=de
Button zum nach oben scrollen